Physician profile
David B Rotton
NPI 1548218803
$1,209.61
in general payments reported to CMS, 2019-2025
10 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.37 · 2020: $16.28 · 2021: $16.15 · 2022: $87.33 · 2023: $67.79 · 2024: $16.18 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $831 · Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $831.32 |
| Food and Beverage | $177.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $855.48 | 2025 | |
| Medtronic, INC. | $86.75 | 2021-2025 | Signia |
| Davol INC. | $76.96 | 2020-2023 | Phasix Mesh |
| Ethicon US, LLC | $60.70 | 2022-2025 | Echelon Flex |
| Organogenesis INC. | $42.42 | 2019 | |
| Tei Biosciences INC | $27.02 | 2019 | |
| Smith+Nephew, INC. | $25.06 | 2022 | |
| Conmed Corporation | $16.18 | 2024 | Airseal, Conmed Pads and Pencils |
| Kci USA, INC. | $11.93 | 2019 | |
| Kerecis Limited | $7.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.